Deep Track Biotechnology Master Fund, Ltd. 13D and 13G filings for Geron Corporation:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-08-14 08:46 am Purchase | 2025-06-30 | 13G | Geron Corporation GERN | Deep Track Biotechnology Master Fund, Ltd. | 43,000,000 6.750% | 8,000,000 (+22.86%) | Filing |
| 2025-03-25 4:06 pm Purchase | 2025-03-18 | 13G | Geron Corporation GERN | Deep Track Biotechnology Master Fund, Ltd. | 35,000,000 5.500% | 27,424,951 (+362.04%) | Filing |
| 2024-11-14 09:31 am Sale | 2024-09-30 | 13G | Geron Corporation GERN | Deep Track Biotechnology Master Fund, Ltd. | 7,575,049 1.260% | -22,008,400 (-74.39%) | Filing |
| 2024-02-14 08:44 am Purchase | 2023-12-31 | 13G | Geron Corporation GERN | Deep Track Biotechnology Master Fund, Ltd. | 29,583,449 5.450% | 5,560,566 (+23.15%) | Filing |
| 2023-01-13 4:14 pm Purchase | 2023-01-06 | 13G | Geron Corporation GERN | Deep Track Biotechnology Master Fund, Ltd. | 24,022,883 5.350% | 24,022,883 (New Position) | Filing |